ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea
· Delayed Price · Currency is KRW 2,300.00
+140.00 (6.48%)
Last updated: Mar 28, 2025
ENBIO Revenue
In the year 2024, ENBIO had annual revenue of 35.65B KRW with 4.79% growth. ENBIO had revenue of 5.17B in the quarter ending December 31, 2024, with 13.56% growth.
Revenue
35.65B
Revenue Growth
+4.79%
P/S Ratio
0.66
Revenue / Employee
445.68M
Employees
80
Market Cap
23.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.65B | 1.63B | 4.79% |
| Dec 31, 2023 | 34.02B | -215.53M | -0.63% |
| Dec 31, 2022 | 34.24B | 773.80M | 2.31% |
| Dec 31, 2021 | 33.47B | -1.10B | -3.17% |
| Dec 31, 2020 | 34.56B | 827.52M | 2.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |